From kill to overkill: 100 years of (perhaps too much) progress

Immunohematology

Volumn 16, Issue 1, 2000, Pages 18-25

  Issitt, P D ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Antibody screening tests; Antiglobulin tests; Automation; Compatibility tests; Enzyme treated red cells; Gel methods; PEG; Polybrene; Solid phase

Indexed keywords

ANTIBODY;

BLOOD COMPATIBILITY; BLOOD GROUP ABO SYSTEM; BLOOD TRANSFUSION; ERYTHROCYTE; HISTORY OF MEDICINE; HUMAN; PRIORITY JOURNAL; REVIEW;

EID: 0034058970     PISSN: 0894203X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (66)

1. Landsteiner, K. Zur Kenntnis der antifermentativen, lytischen und agglutinierenden Wirkungen des Blutserums und der Lymphe. Zbl für Bakt, Parasit und Infekt 1900;27:3V7-62. (This paper was the first to mention discovery of the ABC) groups. However, relatively brief details are given. A more complete account, including mention of the probable importance of the findings in transfusion therapy, appeared one year later in:
2. Landsteiner K. Über Agglutinationserscheinungen normalen menschlichen Blutes. Wien klinWschr 1901:14:1132-4. An English translation of the 1901 paper, by Professor A.L. Kappus. was published in Transfusion 1961: l:S-8).
3. Walton HH. Remarks, statistical and general on transfusion of blood. The MedicalTimes 1849; U 4-7.
4. Ottenberg R. Transfusion and arterial anastomosis. Some experiments in arterial anastomosis and a study of transfusion with presentation of two clinical cases. Ann Surg 1908:47:486-505.
5. Ottenberg R. Studies on isoagglutination. I. Transfusion and the question of intravascular agglutination. J ExpMed 1911:13:425-3.
6. Ottenberg R. Kaliski DJ. Accidents in transfusion. Their prevention by preliminary blood examination: based on experience of one hundred and twentyeight transfusions. J Am Med Assoc 1913: 61: 2138-40.
7. Ottenberg R.Thalheimer W. Studies in experimental transftision. J Med Res 1913:33:213-29-
8. Weil R. Sodium citrate in the transfusion of blood. J AmMedAssoc 1915:64:425-6.
9. Unger IJ. Precautions necessary in the selection of a donor for blood transfusion. J Am Med Assoc 1921:76:9-11.
10. Ottenberg R. Reminiscences of the history of blood transfusion. J Mt Sinai Hosp 193T;4:264-71.
11. Cameron JW. Diamond LK. Chemical, clinical and immunological studies on the products of human plasma tractionation. XXIX. Serum albumin as a diluent for Rh typing reagents. J Clin Invest 1945; 24:93-801.
12. Diamond LK. Denton RL. Rh agglutination in various media with particular reference to the value of albumin. J Lab Clin Med 1945:30:821-30.
13. Diamond LK.Abelson NM.The demonstration of antiRh agglutinins,an accurate and rapid slide test. J lab Clin Med 1945:30:204-12.
14. Diamond LK.Abelson NM.The detection of Rh sensiti/ation: evaluations of tests for Rh antibodies. J Lab Clin Med 1945;30:668-~4.
15. Coombs RRA, Mourant AE. Race RR. A new test for the detection of weak and "incomplete" Rh agglutinins. BrJ Exp Pathol 1945:26:255-66.
16. Moreschi C. Neue Tatsachen über die Blutkörperchen Agglutination. Zbl Bakt 1908; 46:49-51.
17. Coombs RRA. Mourant AE. Race RR. In vivo isosensitization of red cells in babies with hacmolytic disease. Lancet 1946;i:264-6.
18. Pickles MM. Effects of cholera nitrate on red cells as demonstrated by incomplete Rh antibodies. Nature 1946:158:880.
19. Morton JA. Pickles MM. L]se of trypsin in the detec tion of incomplete anti-Rh antibodies. Nature 1947;159:779-81.
20. Low B.A practical method using papain and incomplete Rh-antibodies in routine Rh blood-grouping. Vox Sang (O.S.) 1955:5:94-100.
21. Haber G, Rosenfield RE. Ficin treated red cells for hemaggluti nation studies. In: P.H. AndresenPapers in dedication of his 60th birthday. Copenhagen, Denmark :Munksgaard, 1957:45-65.
22. Pirofsky B, Mangum MEJ. Use of bromelain to demonstrate erythrocyte antibodies. Proc Soc Exp BiolMed 1959:101:49-52.
23. Dodd BE, Eeles DA. Rh antibodies detectable only by enzyme technique. Immunology 1961:4:337-45.
24. Dybkjaer E. Irregular blood group antibodies. A screening test including a two-stage papain technique. Dan Med Bull 1966:13:188-92.
25. Casey FM, Dodd BE, Lincoln PJ.A study of the characteristics of certain Rh antibodies preferentially detectable by enzyme technique. Vox Sang 1972:23:493-507.
26. Friedman BA, Oberman HA, Chadwick AR, Kindgon KI.The maximum surgical blood order schedule and surgical blood use in the United States. Transfusion 1976;l6:380-7.
27. Mintz PD, Nordine RB, Henry JB,WebbWR. Expected hemotherapy in elective surgery. NY State J Med 1976;76:532-7.
28. Boral LI, Henry JB. The type and screen: a safe alternative and supplement in selected surgical procedures. Transfusion 1977; 17:163-8.
29. Oberman HA, Barnes BA, Friedman BA. The risk of abbreviating the major crossmatch in urgent or massive transfusion. Transfusion 1978; 18:137-41,
30. Rouault CL, Gruenhagen J, Reorganization of blood ordering practices. Transfusion 1978;18:448-53-
31. Boral LI, Hill SS, Apollon CJ, Folland A. The type and antibody screen revisited. Am J Clin Pathol 1979;71:578-81.
32. Mintz PD, Haines AL, Sullivan MF. Incompatible crossmatch following nonreactive antibody detection test. Frequency and cause. Transfusion 1982; 22: 107-10.
33. Rouault CL. Appropriate pretransfusion testing. In: Treacy M, ed. Pretransfusion testing for the '80s. Washington, D.C.:AABB, 1980:125-32.
34. Spivak M. The importance of compatibility testing. In:Treacy M, ed. Pretransfusion testing for the '80s. Washington, D.C.:AABB, 1980:133-9-
35. Garratty G.The role of compatibility tests. Report of a meeting sponsored by the Bureau of Biologies for the Blood Products Advisory Committee. Transfusion 1982;22:169-72.
36. Issitt PD, Anstee DJ. Applied blood group serology. 4th ed. Durham, N.C.: Montgomery Scientific Publications, 1998:893-7;876.
37. Mollison PL. Blood transfusion in clinical medicine. 7th ed. Oxford, England: Blackwell Scientific Publications, 1983:541.
38. Judd WJ. Commentary: testing for unexpected red cell antibodies-two or three reagent red cell samples? Immunohematology 1997:13:90-2.
39. Low B, Messeter L. Antiglobulin test in low ionic strength salt solution for rapid antibody screening and cross-matching. Vox Sang 1974;26:53-6l.
40. Leikola J, Perkins HA. Red cell antibodies and low ionic strength: a study with enzyme-linked antiglobulin test.Transfusion 1980;20:224-8.
41. Pinkerton PH, Zuber ED, Barr RM, et al. Sensitivity of routine blood bank methods for the detection of anti-D as determined during proficiency testing. Am J Clin Pathol 1984;82:326-9.
42. Pinkerton PH, Ward J, Chan R, Coovadia AS. An evaluation of a gel technique for antibody screening compared with a conventional tube method. Transnis Med 1993:3:201-5.
43. Pinkerton PH, Chan R, Ward J, Coovadia AS. Sensitivity of column agglutination technology in detecting unexpected red cell antibodies. Transfus Med 1993:3:275-9-
44. Lalezari P, Jiang AF. The manual Polybrene test; a simple and rapid procedure for the detection of red cell antibodies.Transfusion 1980;20:206-11.
45. Plapp FY Sinor LT, Rachel JM, et al.A solid phase antibody screen.Am J Clin Pathol 1984;82:719-21.
46. Nance SJ, Garratty G. Polyethylene glycol. A new potentiator of red blood cell antigen-antibody reactions.AmJ Clin Pathol 1987;87:633-5.
47. Lapierre Y, Rigal D, Adam J, et al.The gel test: a new way to detect red cell antigen-antibody reactions. Transfusion 1990;30:109-13.
48. Judd WJ, Steiner EA, Oberman HA, Nance SJ. Can the reading for sérologie reactivity following 37°C incubation be omitted? Transfusion 1992:32:304-8.
49. Judd WJ, Füllen DR, Steiner EA, et al. Revisiting the issue: can the reading for sérologie reactivity following 37°C incubation be omitted? Transfusion 1999:39:295-9.
50. Issitt PI). Antibody screening: elimination of another piece of the test (editorial). Transfusion 1999: 9:229-O.
51. Issitt PD, Combs MR, Bredehoeft SJ. et al. Lack ofclinical significance of "enzyme-only ' red cell antibodies. Transfusion 199::284-9.
52. Shirey RS. Hoyd JS. Ness PM. Pohth) lene glycol versus low-ionic-strength solution in prctransfusion testing: a blinded comparison study. Transfusion 19944:(S8-7(K
53. Lown J, Willis J. Monocyte monolayer assa\ (MMA) reactivin of alloantibodies reacting b\ the manual polybrene technique but not by an antiglobulin test. TransfusMcd 1995:5:281-4.
54. Issitt PD. Comb MR. Kradshaw T Comparison of a solid phase and polyethylene glycol (PE(i) I AT method in a large transfusion service (abstract). Transfusion 1997;7(Suppl 9S):2SS.
55. Combs MR. Issitt PI). Use of a solid phase method as an adjunct procedure in antibody identification (abstract).Transfusion l W:7(Suppl 9S):lS.
56. Issitt PD. Combs MR. Booth K. Comparison of the MTS-gel and polyethylene glycol (PEG) IAT methods (abstract).Transfusion 1997:7(Suppl 9S):ô4S.
57. Reilly B. DePîUma H. Cosgrovc I Parsi M. Grima K. Comparison between routine tube tests (USS). PR(! tube test, gel technology and solid-phase red cell adherence assays (abstract). Transfusion 199"": j7(Suppl 9S):64S.
58. Alkhashan AA, Combs MR, Issitt PD. Detection of 37°C agglutinins by polyethylene glycol (PEG>IAT (abstract).Transfusion 1997:37(Suppl 9S):28S.
59. Malone RH, Dunsford I.The Rhesus antibody anti-E in pregnancy and blood transfusion. I.The frequency of occurrence of pure anti-E: report of 12 cases. II.The demonstration by pure anti-E serum of dosage effect of the antigen E in the presence or absence of the antigen D. Blood 1951 ;6:1135-46.
60. Vogt E, Krystad E. Heisto H, Myhre K. A second example of a strong anti-E reacting in vitro almost exclusively with enzyme treated E positive red cells. Vox Sang 1958:3:118-23.
61. Kissmeyer-Nielson F.Thc serolog}' of 123 anti-E and 55 anti-c antibodies. Sangre 1964:9:221-6.
62. KisMneyer-Niclsen E Irregular blood group antibodies in 200,000 individuals. Scand J Haematol 1965:2:331-42.
63. Dybkjaer E. Anti-E antibodies disclosed in the period I960-1966.Vox Sang 1967:13:446-8.
64. Harrison J.The "naturally-occurring" anti-E. Vox Sang 190:19:123-31.
65. International forum. What is the best technique for the detection of red cell alloantibodies? Vox Sang 1995:69:292-300.
66. Judd WJ. Modern approaches to pretransfusion testing. Immunohematology 1999:15:41-52.